e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular and clinical diseasome of comorbidities in exacerbated COPD patients
Faner Rosa, Gutiérrez-Sacristán Alba, Castro-Acosta Ady, Grosdidier Solène, Gan Wenqi, Sánchez-Mayor Milagros, Lopez-Campos Jose Luis, Pozo-Rodriguez Francisco, Sanz Ferran, Mannino David, Furlong Laura I., Agusti Alvar
Source:
Eur Respir J 2015; 46: 1001-1010
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Faner Rosa, Gutiérrez-Sacristán Alba, Castro-Acosta Ady, Grosdidier Solène, Gan Wenqi, Sánchez-Mayor Milagros, Lopez-Campos Jose Luis, Pozo-Rodriguez Francisco, Sanz Ferran, Mannino David, Furlong Laura I., Agusti Alvar. Molecular and clinical diseasome of comorbidities in exacerbated COPD patients. Eur Respir J 2015; 46: 1001-1010
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Prevalence of comorbidities in patients with COPD in south-Spain
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
COPD comorbidities network
Source: Eur Respir J 2015; 46: 640-650
Year: 2015
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Comparison between COPD and non-COPD patients with established cardiovascular diseases: A profiling of respiratory symptoms and functional status
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Molecular and cytological features of occupational chronic obstructive pulmonary disease in subjects exposed to different environmental factors
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015
Impact of co-morbidities on the rehabilitation outcome in COPD patients
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype?
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014
Cardiovascular comorbidity in severe COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
Source: International Congress 2014 – COPD markers
Year: 2014
Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Information on coexisting diseases in patient files in newly referred COPD patients in the KOLibri study
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
COPD and comorbidities
Source: Annual Congress 2009 - COPD comorbidities: translational approaches
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept